Bicycle Therapeutics
Nigel Crockett is an experienced professional in the biotech and pharmaceutical industry, currently serving as the Chief Business Officer at Bicycle Therapeutics. With a background in business development and consultancy, Nigel has held various leadership roles in companies such as Tukan Partners Ltd, Trig1, Microbiotica Ltd, NodThera Limited, Crescendo Biologics Limited, Psioxus Therapeutics, Medivir AB, Heptares, and Iconix Biosciences. Nigel holds a PhD from Cambridge University and a BSc from The University of Manchester.
This person is not in any offices
Bicycle Therapeutics
2 followers
Bicycle is pioneering a new class of therapies based on its bicyclic peptide platform.